Our top pick for
HC2 Holdings Inc is a telecom services business based in the US. HC2 shares (HCHC) are listed on the NYSE and all prices are listed in US Dollars. HC2 employs 2,803 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.72|
|52-week range||$2.06 - $4.64|
|50-day moving average||$3.74|
|200-day moving average||$3.90|
|Wall St. target price||$5.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.55|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||-3.88%|
|1 month (2021-09-17)||1.09%|
|3 months (2021-07-19)||8.14%|
|6 months (2021-04-19)||1.64%|
|1 year (2020-10-19)||58.30%|
|2 years (2019-10-18)||71.43%|
|3 years (2018-10-19)||5.33|
|5 years (2016-10-19)||4.95|
Valuing HC2 stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HC2's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HC2's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.2 million.
The EBITDA is a measure of a HC2's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||1.61%|
|Gross profit TTM||$167.3 million|
|Return on assets TTM||0.16%|
|Return on equity TTM||-21.3%|
|Market capitalisation||$286.4 million|
TTM: trailing 12 months
There are currently 3.0 million HC2 shares held short by investors – that's known as HC2's "short interest". This figure is 6% down from 3.2 million last month.
There are a few different ways that this level of interest in shorting HC2 shares can be evaluated.
HC2's "short interest ratio" (SIR) is the quantity of HC2 shares currently shorted divided by the average quantity of HC2 shares traded daily (recently around 307417.36896197). HC2's SIR currently stands at 9.73. In other words for every 100,000 HC2 shares traded daily on the market, roughly 9730 shares are currently held short.
However HC2's short interest can also be evaluated against the total number of HC2 shares, or, against the total number of tradable HC2 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HC2's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 HC2 shares in existence, roughly 40 shares are currently held short) or 0.0639% of the tradable shares (for every 100,000 tradable HC2 shares, roughly 64 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HC2.
Find out more about how you can short HC2 stock.
We're not expecting HC2 to pay a dividend over the next 12 months.
HC2's shares were split on 27 August 2013.
Over the last 12 months, HC2's shares have ranged in value from as little as $2.06 up to $4.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while HC2's is 2.3046. This would suggest that HC2's shares are significantly more volatile than the average for this exchange and represent a higher risk.
HC2 Holdings, Inc. , through its subsidiaries, provides construction, insurance, life sciences, broadcasting, and other services in the United States, the United Kingdom, and internationally. The company models, details, fabricates, and erects structural steel for commercial and industrial, and infrastructure construction projects, including building and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. It also fabricates trusses and girders; and fabricates and erects water pipes, water storage tanks, pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. In addition, the company provides equipment for the oil and gas industry. Further, it offers long-term care, life, annuity, and other accident and health coverage; focuses on developing products for early osteoarthritis of the knee, as well as skin lightening technology; and operates over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network. The company was formerly known as PTGi Holding Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.